Sundance Strategies (SUND) 10-Q 15 Nov 21 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Sep. 30, 2021	Nov. 15, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--03-31
Entity File Number	000-50547
Entity Registrant Name	SUNDANCE STRATEGIES, INC.
Entity Central Index Key	0001171838
Entity Tax Identification Number	88-0515333
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	4626 North 300 West
Entity Address, Address Line Two	Suite No. 365
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84604
City Area Code	(801)
Local Phone Number	717-3935
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	SUND
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		41,348,441

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2021	Mar. 31, 2021
Current Assets
Cash and cash equivalents	$ 939	$ 21,179
Prepaid expenses and other assets	17,643	9,393
Total Current Assets	18,582	30,572
Current Liabilities
Accounts payable	551,216	893,675
Accrued expenses	410,291	215,443
Notes payable	300,000
Current portion of notes payable, related parties	876,000	826,000
Stock repurchase payable	400,000	400,000
Total Current Liabilities	2,537,507	2,335,118
Long-Term Liabilities
Accrued expenses	453,269	495,708
Notes payable, related parties, net of current portion	2,025,808	1,915,808
Total Long-Term Liabilities	2,479,077	2,411,516
Total Liabilities	5,016,584	4,746,634
Stockholders’ Deficit
Preferred stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common stock, authorized 500,000,000 shares, par value $0.001; 41,308,441 and 40,108,441 shares issued and outstanding as of September 30, 2021 and March 31, 2021, respectively	41,309	40,109
Additional paid in capital	24,801,358	24,728,638
Accumulated deficit	(29,840,669)	(29,484,809)
Total Stockholders’ Deficit	(4,998,002)	(4,716,062)
Total Liabilities and Stockholders’ Deficit	$ 18,582	$ 30,572

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2021	Mar. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock par value	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	500,000,000	500,000,000
Common stock par value	$ 0.001	$ 0.001
Common stock, shares issued	40,108,441	41,308,441
Common stock, shares outstanding	40,108,441	41,308,441

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Income from Investments
General and Administrative Expenses	172,144	235,918	415,605	360,259
Loss from Operations	(172,144)	(235,918)	(415,605)	(360,259)
Other Income (Expense)
Gain on settlement of liabilities			285,192
Interest expense	(68,352)	(55,945)	(133,737)	(108,190)
Financing expense	(10,000)	(40,730)	(87,561)	(115,230)
Total Other Income (Expense)	(78,352)	(96,675)	63,894	(223,420)
Loss Before Income Taxes	(250,496)	(332,593)	(351,711)	(583,679)
Income Tax Provision (Benefit)	4,149		4,149
Net Loss	$ (254,645)	$ (332,593)	$ (355,860)	$ (583,679)
Loss per share - basic and diluted	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.02)
Weighted average shares outstanding - basic and diluted	41,308,441	37,828,441	41,086,702	37,828,441

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2020	$ 37,829	$ 24,191,224	$ (27,955,242)	$ (3,726,189)
Beginning balance, shares at Mar. 31, 2020	37,828,441
Net loss			(251,086)	(251,086)
Ending balance, value at Jun. 30, 2020	$ 37,829	24,191,224	(28,206,328)	(3,977,275)
Ending balance, shares at Jun. 30, 2020	37,828,441
Beginning balance, value at Mar. 31, 2020	$ 37,829	24,191,224	(27,955,242)	(3,726,189)
Beginning balance, shares at Mar. 31, 2020	37,828,441
Net loss				(583,679)
Ending balance, value at Sep. 30, 2020	$ 37,829	24,191,224	(28,538,921)	(4,309,868)
Ending balance, shares at Sep. 30, 2020	37,828,441
Beginning balance, value at Jun. 30, 2020	$ 37,829	24,191,224	(28,206,328)	(3,977,275)
Beginning balance, shares at Jun. 30, 2020	37,828,441
Net loss			(332,593)	(332,593)
Ending balance, value at Sep. 30, 2020	$ 37,829	24,191,224	(28,538,921)	(4,309,868)
Ending balance, shares at Sep. 30, 2020	37,828,441
Beginning balance, value at Mar. 31, 2021	$ 40,109	24,728,638	(29,484,809)	(4,716,062)
Beginning balance, shares at Mar. 31, 2021	40,108,441
Common stock issued for director compensation	$ 1,200	54,240		55,440
Common stock issued for director compensation, shares	1,200,000
Net loss			(101,215)	(101,215)
Ending balance, value at Jun. 30, 2021	$ 41,309	24,782,878	(29,586,024)	(4,761,837)
Ending balance, shares at Jun. 30, 2021	41,308,441
Beginning balance, value at Mar. 31, 2021	$ 40,109	24,728,638	(29,484,809)	(4,716,062)
Beginning balance, shares at Mar. 31, 2021	40,108,441
Net loss				(355,860)
Ending balance, value at Sep. 30, 2021	$ 41,309	24,801,358	(29,840,669)	(4,998,002)
Ending balance, shares at Sep. 30, 2021	41,308,441
Beginning balance, value at Jun. 30, 2021	$ 41,309	24,782,878	(29,586,024)	(4,761,837)
Beginning balance, shares at Jun. 30, 2021	41,308,441
Stock-based compensation - director shares		18,480		18,480
Net loss			(254,645)	(254,645)
Ending balance, value at Sep. 30, 2021	$ 41,309	$ 24,801,358	$ (29,840,669)	$ (4,998,002)
Ending balance, shares at Sep. 30, 2021	41,308,441

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating Activities
Net Loss	$ (355,860)	$ (583,679)
Adjustments to reconcile to net cash used in operating activities:
Share based compensation - common stock	73,920
Expense paid on behalf of Company by director		7,000
Gain on settlement of liabilities	(285,192)
Changes in operating assets and liabilities
Prepaid expenses and other assets	(8,250)
Accounts payable	(57,267)	141,479
Accrued expenses	152,409	143,910
Net Cash used in Operating Activities	(480,240)	(291,290)
Financing Activities
Proceeds from issuance of notes payable, related party	160,000	238,500
Proceeds from issuance of Notes payable	300,000
Proceeds from Paycheck Protection Program loan		26,458
Net Cash provided by Financing Activities	460,000	264,958
Net Change in Cash and Cash Equivalents	(20,240)	(26,332)
Cash and Cash Equivalents at Beginning of Period	21,179	28,784
Cash and Cash Equivalents at End of Period	939	2,452
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes

BASIS OF PRESENTATION, ORGANIZA

BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	(1) BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and reflect the financial position, results of operations and cash flows of the Company. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, which was filed with the SEC on June 29, 2021. The results from operations for the three-month period ended September 30, 2021, are not necessarily indicative of the results that may be expected for the fiscal year ended March 31, 2022. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates. Organization and Nature of Operations Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies”, “the Company”, “we” or “our”). Our historical business model has focused on purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part of or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” During the latter part of the fiscal year ended March 31, 2021, the Company began developing an additional business offering, providing professional services to specialty structured finance groups, bond issuers and life settlement aggregators. The Company has now assembled an experienced team from the life settlement marketplace, as well as from other areas such as financial services and public financial markets. As a professional services provider, the Company applies industry best practices to advise on the selection of specific portfolios of life insurance policies that are tailored to meet the needs of its clients. The Company’s clients may include bond issuers, bond investors, or other structured finance product issuers. The Company develops strategies and methodologies which include the acquisition of life insurance portfolios, then uses common structured finance techniques and proprietary analytics to structure bonds for issuances, including principal protected bonds. The Company’s goal is to deliver long-term value and profitability to shareholders by growing the Company’s professional services business and asset base, resulting in the ability to pay dividends to its shareholders. Most recently the Company began working closely with bond placement agents and aggregators to establish various aspects of a proprietary, investment grade bond offering. In this arrangement, the Company participates as the sole originator in the role of structuring and advising on the structure of the proprietary bond instrument. Included in the role of structuring financial assets, the Company uses proprietary analytics to establish the makeup of the rated instrument, including but not limited to, life settlement assets (life insurance policies) and managed cash, and implements a process of selective assembly of the underlying assets and cash management that will meet the policy requirements and analytics. The Company provides current and ongoing resources for all analytics, as well as advisement support for the investment and non-investment grade ratings for the managed asset pool and the managed cash accounts. In its advisory role, the Company is reimbursed for all expenses associated with the structuring and preparation of any bond offering, will receive an advisory payment upon the closing of any bond offering, and then will hold residual rights on the balance of assets once the bond is retired. SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) September 30, 2021 During the quarter ended June 30, 2021, the Company and US Capital Global Securities LLC, an affiliate of US Capital Global, entered into an arrangement wherein the Company is the lead advisor and lead originator of tailored life insurance portfolios to be used in a life insurance-linked bond offering (“bond offering”) of between $ 250 500 40 Significant Accounting Policies There have been no changes to the significant accounting policies of the Company from the information provided in Note 2 of the Notes to Consolidated Financial Statements in the Company’s most recent Form 10-K, except as discussed below. Basic and Diluted Net Income (Loss) Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods presented using the treasury stock method. Diluted net loss per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable. Potential dilutive common stock equivalents are primarily comprised of potential dilutive shares resulting from convertible debt agreements and common stock warrants. Potentially dilutive shares resulting from convertible debt agreements are evaluated using the if-converted method. Potentially dilutive securities are not included in the calculation of diluted net loss per share for the three and six months ended September 30, 2021 and 2020, because to do so would be anti-dilutive. Potentially dilutive securities outstanding as of September 30, 2021 and 2020 are comprised of warrants convertible into 4,758,754 2,133,000 New Accounting Pronouncements Not Yet Adopted The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements. SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) September 30, 2021

LIQUIDITY REQUIREMENTS

LIQUIDITY REQUIREMENTS	6 Months Ended
	Sep. 30, 2021
Liquidity Requirements
LIQUIDITY REQUIREMENTS	(2) LIQUIDITY REQUIREMENTS Since the Company’s inception on January 31, 2013, its operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. As of September 30, 2021, the Company had $ 939 21,179 4,704,192 2,700,000 70,000 70,000 6,000 64,000 10,000 400,000 551,216 The outbreak of COVID-19 originated in Wuhan, China, in December 2019 and has since spread to multiple countries, including the United States and several European countries. On March 11, 2020, the World Health Organization declared the outbreak a pandemic. The COVID-19 pandemic is affecting the United States and global economies and may affect the Company’s operations and those of third parties on which the Company relies. While the potential economic impact brought by, and the duration of, the COVID-19 pandemic is difficult to assess or predict, the impact of the COVID-19 pandemic on the global financial markets may reduce the Company’s ability to access capital, which could negatively impact the Company’s short-term and long-term liquidity. The ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. The Company does not yet know the full extent of potential delays or impacts on its business, financing or other activities or on healthcare systems or the global economy as a whole. However, these effects could have a material impact on the Company’s liquidity, capital resources, operations and business and those of the third parties on which we rely. The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	(3) FAIR VALUE MEASUREMENTS As defined by ASC Topic 820, “Fair Value Measurements and Disclosures” (“ASC 820”), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also requires the consideration of differing levels of inputs in the determination of fair values. Those levels of input are summarized as follows: ● Level 1: Quoted prices in active markets for identical assets and liabilities. ● Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. ● Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques as well as instruments for which the determination of fair value requires significant management judgment or estimation. SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) September 30, 2021 The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company did not have any transfers of assets and liabilities between Levels 1, 2 and 3 of the fair value measurement hierarchy during the six months ended September 30, 2021 and 2020. Other Financial Instruments The Company’s recorded values of cash and cash equivalents, prepaid expenses and other assets, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded values of the notes payable and convertible debenture approximate the fair values as the interest rate approximates market interest rates.

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	6 Months Ended
	Sep. 30, 2021
Equity [Abstract]
STOCKHOLDERS’ EQUITY	(4) STOCKHOLDERS’ EQUITY Common Stock On May 4, 2021, the Company issued 1,200,000 25 0.062 73,920 55,440 Warrants to Purchase Common Stock The following table summarizes the changes in warrants outstanding of the Company during the six months ended September 30, 2021: SCHEDULE OF WARRANT OUTSTANDING Number of Warrants Weighted Average Exercise Price ($) Outstanding at March 31, 2021 3,488,754 $ 0.05 Granted 1,270,000 $ 0.87 Outstanding at September 30, 2021 4,758,754 $ 0.27 During the fiscal year ended March 31, 2021, the Company’s related party lenders consisting of: the Chairman of the Board of Directors and a stockholder, Radiant Life, LLC and Mr. Dickman, the holder of the related party unsecured promissory notes, all amended their agreements to provide each related party with common stock warrants upon the lender’s extension of a maturity due date or upon the loaning of additional monies. The number of warrants issued for an extension is based on the following formula: 10,000 warrants per month the due date is extended plus 1 warrant for every $2 of the principal balance outstanding (not including interest) at the time of the extension (rounded to the nearest whole warrant) 0.05 5 During the six months ended September 30, 2021, the Company issued 200,000 20,000 On April 6, 2021, the Company borrowed $ 300,000 under an unsecured promissory note with Satco International, Ltd. (see Note 5). In conjunction with this note, the Company issued a warrant for 1,000,000 shares of common stock, exercisable at $ 1.00 per share and expiring in 3 years from the date of the promissory note. The value of the warrants on the date of grant, as calculated by the Black-Scholes-Merton valuation model, was not significant. The inputs used in this calculation included a fair value of $ 0.062 per share, a risk-free rate of 0.35 %, volatility of 50.3 % and a dividend rate of 0 %. On July 29, 2021, the Company borrowed an additional $ 50,000 50,000 2.00 5 The following table summarizes the warrants issued and outstanding as of September 30, 2021: SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING Exercise Price ($) Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life (Years) Proceeds to Company if Exercised ($) 0.05 3,708,754 3,708,754 3.93 185,438 1.00 1,000,000 1,000,000 2.52 1,000,000 2.00 50,000 50,000 4.84 100,000 4,758,754 4,758,754 1,285,438 The estimated fair value of the warrants on the date of grant, as calculated by the Black-Scholes-Merton valuation model, was not significant. The average remaining outstanding life of the warrants as of March 31, 2021, was 3.47 SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) September 30, 2021

NOTES PAYABLE

NOTES PAYABLE	6 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
NOTES PAYABLE	(5) NOTES PAYABLE On April 6, 2021, the Company borrowed $ 300,000 unsecured promissory note with Satco International, Ltd. 8 unsecured promissory note with Satco International, Ltd. was amended to extend the due date from October 6, 2021 to January 6, 2022, 8 % convertible debenture agreement that the Company has in place with Satco International, Ltd. In conjunction with this note, the Company issued warrants for 1,000,000 1.00 3 11,638

NOTES PAYABLE, RELATED PARTY

NOTES PAYABLE, RELATED PARTY	6 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
NOTES PAYABLE, RELATED PARTY	(6) NOTES PAYABLE, RELATED PARTY As of September 30, 2021, and March 31, 2021, the Company had borrowed $ 2,901,808 2,741,808 635,765 513,665 Related Party Promissory Notes As of both September 30, 2021 and March 31, 2021, the Company owed $ 826,000 8 November 30, 2021 181,800 On July 29, 2021, the Company entered into an unsecured promissory note agreement with Radiant Life, LLC. This agreement was in conjunction with the Company borrowing $ 50,000 8 50,000 2.00 expire in 5 695 Related Party Note Payable and Line of Credit Agreements As of September 30, 2021 and March 31, 2021 1,066,300 1,056,300 November 30, 2022 September 30, 2021 4,600,000 10,000 7.5 September 30, 2021 182,304 20,000 10,000 1,727,000 September 30, 2021 0.05 5 SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) September 30, 2021 As of September 30, 2021 and March 31, 2021, the Company owed $ 959,508 859,508 2,130,000 November 30, 2022 7.5 100,000 270,966 200,000 100,000 0.05 5 The total number of warrants issued to the related party lender, including the warrants issued in conjunction with the one-time lending event, was 829,754 September 30, 2021

CONVERTIBLE DEBENTURE AGREEMENT

CONVERTIBLE DEBENTURE AGREEMENT	6 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
CONVERTIBLE DEBENTURE AGREEMENT	(7) CONVERTIBLE DEBENTURE AGREEMENT The Company has entered into an 8 3,000,000 Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90-day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $ 1.00 June 2, 2016 July 5, 2021 note was amended to extend the due date from July 5, 2021 to November 30, 2021, As of September 30, 2021 and March 31, 2021, the Company owed $ 0 124,225

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(8) SUBSEQUENT EVENTS Subsequent to September 30, 2021, the following events transpired: On November 5, 2021, the Company issued a private placement memorandum offering to raise up to $ 500,000 0.001 40,000 5 200,000 5 five years 200,000 On November 9, 2021 the unsecured promissory note with Satco International, Ltd. (see Note 5) was amended to extend the due date from October 6, 2021 to January 6, 2022, or at the immediate time when alternative financing or other proceeds are received. This extension has no bearing on the warrants that were issued in conjunction with the original promissory note.

BASIS OF PRESENTATION, ORGANI_2

BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basic and Diluted Net Income (Loss) Per Common Share	Basic and Diluted Net Income (Loss) Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods presented using the treasury stock method. Diluted net loss per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable. Potential dilutive common stock equivalents are primarily comprised of potential dilutive shares resulting from convertible debt agreements and common stock warrants. Potentially dilutive shares resulting from convertible debt agreements are evaluated using the if-converted method. Potentially dilutive securities are not included in the calculation of diluted net loss per share for the three and six months ended September 30, 2021 and 2020, because to do so would be anti-dilutive. Potentially dilutive securities outstanding as of September 30, 2021 and 2020 are comprised of warrants convertible into 4,758,754 2,133,000
New Accounting Pronouncements	New Accounting Pronouncements Not Yet Adopted The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements. SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) September 30, 2021

STOCKHOLDERS_ EQUITY (Tables)

STOCKHOLDERS’ EQUITY (Tables)	6 Months Ended
	Sep. 30, 2021
Equity [Abstract]
SCHEDULE OF WARRANT OUTSTANDING	The following table summarizes the changes in warrants outstanding of the Company during the six months ended September 30, 2021: SCHEDULE OF WARRANT OUTSTANDING Number of Warrants Weighted Average Exercise Price ($) Outstanding at March 31, 2021 3,488,754 $ 0.05 Granted 1,270,000 $ 0.87 Outstanding at September 30, 2021 4,758,754 $ 0.27
SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING	The following table summarizes the warrants issued and outstanding as of September 30, 2021: SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING Exercise Price ($) Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life (Years) Proceeds to Company if Exercised ($) 0.05 3,708,754 3,708,754 3.93 185,438 1.00 1,000,000 1,000,000 2.52 1,000,000 2.00 50,000 50,000 4.84 100,000 4,758,754 4,758,754 1,285,438

BASIS OF PRESENTATION, ORGANI_3

BASIS OF PRESENTATION, ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) $ in Millions	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Line Items]
Antidilutive Securities	4,758,754	2,133,000
US Capital Global Securities LLC [Member] | Bond Offering [Member]
Property, Plant and Equipment [Line Items]
Percentage of cash received on offering	40.00%
US Capital Global Securities LLC [Member] | Bond Offering [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Cash received from offering	$ 250
US Capital Global Securities LLC [Member] | Bond Offering [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Cash received from offering	$ 500

LIQUIDITY REQUIREMENTS (Details

LIQUIDITY REQUIREMENTS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2021
Liquidity Requirements
Cash and Cash Equivalents, at Carrying Value	$ 939		$ 939		$ 21,179
[custom:AdditionalBorrowingCapacityFromRelatedPartyNotesPayable-0]	4,704,192		4,704,192
[custom:AdditionalBorrowingCapacityOnConvertibleDebenture-0]	2,700,000		2,700,000
Operating Expenses			70,000
[custom:DecreaseInMonthlyExpenses]			6,000
Debt Instrument, Periodic Payment			64,000
Financing Interest Expense	10,000	$ 40,730	87,561	$ 115,230
[custom:AdditionalFinancingAlternatives]			400,000
Accounts Payable, Current	$ 551,216		$ 551,216		$ 893,675

SCHEDULE OF WARRANT OUTSTANDING

SCHEDULE OF WARRANT OUTSTANDING (Details)	6 Months Ended
	Sep. 30, 2021$ / sharesshares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants outstanding, Ending	4,758,754
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants outstanding, Beginning	3,488,754
Weighted average exercise price, Beginning | $ / shares	$ 0.05
Number of warrants, granted	1,270,000
Weighted average exercise price, Granted | $ / shares	$ 0.87
Number of warrants outstanding, Ending	4,758,754
Weighted average exercise price, Ending | $ / shares	$ 0.27

SCHEDULE OF WARRANTS ISSUED AND

SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING (Details)	6 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Outstanding	4,758,754
Warrants Exercisable	4,758,754
Proceeds from warrant exercised | $	$ 1,285,438
Exercise Price One [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant exercise price | $ / shares	$ 0.05
Warrant Outstanding	3,708,754
Warrants Exercisable	3,708,754
Weighted Average Remaining Contractual Life (Years)	3 years 11 months 4 days
Proceeds from warrant exercised | $	$ 185,438
Exercise Price Two [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant exercise price | $ / shares	$ 1
Warrant Outstanding	1,000,000
Warrants Exercisable	1,000,000
Weighted Average Remaining Contractual Life (Years)	2 years 6 months 7 days
Proceeds from warrant exercised | $	$ 1,000,000
Exercise Price Three [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant exercise price | $ / shares	$ 2
Warrant Outstanding	50,000
Warrants Exercisable	50,000
Weighted Average Remaining Contractual Life (Years)	4 years 10 months 2 days
Proceeds from warrant exercised | $	$ 100,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	Jul. 29, 2021	May 04, 2021	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2021	Apr. 06, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Compensation expense					$ 73,920
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right	50,000
Proceeds from Issuance of Debt					$ 300,000
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2]							3 years 5 months 19 days
Unsecured Promissory Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 1
Warrant term								3 years
Notes Payable	$ 50,000							$ 300,000
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right								1,000,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Notes Payable								$ 100,000
Radiant Life LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant term	5 years
Radiant Life LLC [Member] | Unsecured Promissory Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 2
Radian Life LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2						$ 0.05
Warrant term	5 years						5 years
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right	50,000
Proceeds from Issuance of Debt	$ 50,000
Radian Life LLC [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants issued					200,000
Notes Payable And Lines Of Credit Agree [Member] | Radiant Life LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant or Right, Reason for Issuance, Description							The number of warrants issued for an extension is based on the following formula: 10,000 warrants per month the due date is extended plus 1 warrant for every $2 of the principal balance outstanding (not including interest) at the time of the extension (rounded to the nearest whole warrant)
Director [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock issued of compensation		1,200,000
Percentage of stock awards vested		25.00%
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValuePerShare-0]		$ 0.062
Compensation expense			$ 73,920	$ 55,440
Chief Executive Officer [Member] | Radian Life LLC [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants issued					20,000
Mr. Dickman [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share Price			$ 0.062		$ 0.062
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate					0.35%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate					50.30%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate					0.00%

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)	Sep. 30, 2021	Jul. 29, 2021	Apr. 06, 2021
Short-term Debt [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		50,000
Interest Receivable	$ 11,638
Unsecured Promissory Note [Member]
Short-term Debt [Line Items]
Notes Payable		$ 50,000	$ 300,000
Debt Instrument, Interest Rate, Stated Percentage			8.00%
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 1
Warrants and Rights Outstanding, Term			3 years
Convertible Debenture [Member]
Short-term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			8.00%

NOTES PAYABLE, RELATED PARTY (D

NOTES PAYABLE, RELATED PARTY (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2021	Jul. 29, 2021	Apr. 06, 2021	Mar. 31, 2021
Short-term Debt [Line Items]
Notes payable, related parties	$ 2,901,808			$ 2,741,808
Accrued interest	635,765			513,665
Warrants purchase for common stock		50,000
Interest received	11,638
Warrant [Member]
Short-term Debt [Line Items]
Note payable			$ 100,000
Notes Payable And Lines of Credit Agreement [Member]
Short-term Debt [Line Items]
Notes payable, related parties	1,066,300			1,056,300
Notes Payable And Lines of Credit Agreement [Member] | Maximum [Member]
Short-term Debt [Line Items]
Note payable	$ 4,600,000
Notes Payable And Lines of Credit Agreement [Member] | Extended Maturity [Member]
Short-term Debt [Line Items]
Debt instrument due date, description	November 30, 2022
Line of Credit Agreement [Member]
Short-term Debt [Line Items]
Warrants exercise price	$ 0.05
Repayment of debt	$ 10,000
Line of Agreement [Member]
Short-term Debt [Line Items]
Warrants purchase for common stock	20,000
Line of Credit [Member]
Short-term Debt [Line Items]
Note payable			$ 10,000
Radiant Life LLC [Member]
Short-term Debt [Line Items]
Warrant term		5 years
Radiant Life LLC [Member] | Warrant [Member]
Short-term Debt [Line Items]
Number of shares issued	200,000
Radiant Life LLC [Member] | Notes Payable And Lines of Credit Agreement [Member]
Short-term Debt [Line Items]
Notes payable, related parties	$ 959,508			$ 859,508
Note payable	$ 100,000
Radiant Life LLC [Member] | Notes Payable And Lines of Credit Agreement [Member] | The Company's NIBS [Member]
Short-term Debt [Line Items]
Debt instrument interest rate	7.50%
Radiant Life LLC [Member] | Notes Payable And Lines of Credit Agreement [Member] | Maximum [Member]
Short-term Debt [Line Items]
Note payable	$ 2,130,000
Radiant Life LLC [Member] | Notes Payable And Lines of Credit Agreement [Member] | Extended Maturity [Member]
Short-term Debt [Line Items]
Debt instrument due date, description	November 30, 2022
Radian Life LLC [Member]
Short-term Debt [Line Items]
Warrants purchase for common stock		50,000
Warrants exercise price		$ 2		$ 0.05
Warrant term		5 years		5 years
Radian Life LLC [Member] | Notes Payable And Lines of Credit Agreement [Member] | The Company's NIBS [Member]
Short-term Debt [Line Items]
Accrued interest	$ 182,304
The Company's NIBS [Member] | Notes Payable And Lines of Credit Agreement [Member]
Short-term Debt [Line Items]
Accrued interest	$ 270,966
Warrants exercise price	$ 0.05
Warrant term	5 years
Related Party Lender [Member] | Notes Payable And Lines of Credit Agreement [Member]
Short-term Debt [Line Items]
Warrants purchase for common stock	1,727,000
Lender [Member]
Short-term Debt [Line Items]
Repayment of debt	$ 829,754
Unsecured Promissory Note [Member]
Short-term Debt [Line Items]
Accrued interest	181,800
Debt instrument interest rate			8.00%
Note payable		$ 50,000	$ 300,000
Warrants purchase for common stock			1,000,000
Warrants exercise price			$ 1
Warrant term			3 years
Unsecured Promissory Note [Member] | Radiant Life LLC [Member]
Short-term Debt [Line Items]
Warrants exercise price			$ 2
Unsecured Promissory Note [Member] | Mr. Glenn S. Dickman [Member]
Short-term Debt [Line Items]
Notes payable, related parties	$ 826,000			$ 826,000
Debt instrument interest rate	8.00%			8.00%
Unsecured Note Payable [Member]
Short-term Debt [Line Items]
Interest received	$ 695

CONVERTIBLE DEBENTURE AGREEME_2

CONVERTIBLE DEBENTURE AGREEMENT (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2021	Mar. 31, 2021
Debt Instrument [Line Items]
Amount payable	$ 0	$ 0
Accrued interest	$ 124,225	$ 124,225
8% Convertible Debenture Agreement [Member] | Satco International, Ltd., [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Debt Instrument, Convertible, Terms of Conversion Feature	Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90-day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $
Debt Instrument, Convertible, Conversion Price	$ 1
Debt Instrument, Maturity Date	Jun. 2, 2016
8% Convertible Debenture Agreement [Member] | Satco International, Ltd., [Member] | Extended Maturity [Member]
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	Jul. 5, 2021
8% Convertible Debenture Agreement [Member] | Satco International, Ltd., [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 3,000,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Nov. 05, 2021	Sep. 30, 2021	Mar. 31, 2021
Subsequent Event [Line Items]
Common stock par value		$ 0.001	$ 0.001
Warrants exercisable		4,758,754
Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock par value	$ 0.001
Subsequent Event [Member] | Subscription Agreement [Member] | Stockholder [Member]
Subsequent Event [Line Items]
Number of shares issued during period	40,000
Common shares purchase price	$ 5
Warrants exercisable	200,000
Warrant exercise price	$ 5
Warrant term	5 years
Proceeds from common stock	$ 200,000
Subsequent Event [Member] | Private Placement [Member] | Restricted Stock [Member]
Subsequent Event [Line Items]
Number of shares issued during period	500,000